Skip to main content
logo
Ginkgo Bioworks Holdings, Inc. (DNA)
NYSE: DNA · Real-Time Price · USD
10.80
+0.34 (3.25%)
Sep 29, 2026, 10:47 AM EDT - Market open

Ginkgo Bioworks Holdings Operating Metrics

Period EndingSep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021
Active Programs
102.00120.00123.00138.00183.00158.00140.00131.00UpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgrade
Active Programs Growth
-44.26%-24.05%-12.14%5.34%57.76%50.48%44.33%36.46%UpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgrade
Active Customers
---85.0081.0082.0082.0080.0076.0063.0060.00UpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgrade
Active Customers Growth
---6.25%6.58%30.16%36.67%48.15%76.74%75.00%87.50%UpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgrade

Revenue by Segment

Period EndingJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021
Cell Engineering
95.01M113.99M132.75M141.53M187.24M184.31M173.97M166.16MUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgrade
Cell Engineering Growth
-49.26%-38.15%-23.70%-14.82%46.00%34.22%21.21%-2.15%UpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgrade
Biosecurity Services
16.85M27.32M37.41M39.07M43.57M53.10M53.07M51.79MUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgrade
Biosecurity Services Growth
-61.33%-48.55%-29.51%-24.56%-12.14%-1.82%-32.80%-50.10%UpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgrade

Operating Income by Segment

Period EndingJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021
Biosecurity
-8.93M-13.75M-18.93M-24.63M-25.96M-24.59M-30.62M-32.55MUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgrade
Cell Engineering
-182.57M-135.32M-95.53M-116.40M-93.11M-178.98M-239.65M-312.58MUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgrade

Operating Expense Breakdown

Period EndingJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021
Research & Development
215.61M222.77M243.77M270.02M277.68M358.53M424.06M464.72MUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgrade
Research & Development Growth
-22.35%-37.87%-42.51%-41.90%-48.99%-35.34%-26.96%-27.92%UpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgrade
General & Administrative
159.57M172.08M183.29M194.57M201.91M224.92M246.16M278.09MUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgrade
General & Administrative Growth
-20.97%-23.49%-25.54%-30.03%-34.41%-34.59%-36.07%-33.35%UpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgrade